Annual D&A
$3.79 M
+$803.00 K+26.92%
December 31, 2024
Summary
- As of March 10, 2025, OCUL annual depreciation & amortization is $3.79 million, with the most recent change of +$803.00 thousand (+26.92%) on December 31, 2024.
- During the last 3 years, OCUL annual D&A has risen by +$1.36 million (+56.38%).
- OCUL annual D&A is now at all-time high.
Performance
OCUL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$951.00 K
-$8000.00-0.83%
December 31, 2024
Summary
- As of March 10, 2025, OCUL quarterly depreciation & amortization is $951.00 thousand, with the most recent change of -$8000.00 (-0.83%) on December 31, 2024.
- Over the past year, OCUL quarterly D&A has stayed the same.
- OCUL quarterly D&A is now -0.83% below its all-time high of $959.00 thousand, reached on September 30, 2024.
Performance
OCUL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$3.79 M
-$7000.00-0.18%
December 31, 2024
Summary
- As of March 10, 2025, OCUL TTM depreciation & amortization is $3.79 million, with the most recent change of -$7000.00 (-0.18%) on December 31, 2024.
- Over the past year, OCUL TTM D&A has stayed the same.
- OCUL TTM D&A is now -0.18% below its all-time high of $3.79 million, reached on September 30, 2024.
Performance
OCUL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
OCUL Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.9% | 0.0% | 0.0% |
| 3 y3 years | +56.4% | 0.0% | 0.0% |
| 5 y5 years | +49.6% | 0.0% | 0.0% |
OCUL Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +79.5% | -0.8% | +96.9% | -0.2% | +86.0% |
| 5 y | 5-year | at high | +79.5% | -0.8% | +96.9% | -0.2% | +86.0% |
| alltime | all time | at high | +837.1% | -0.8% | +933.7% | -0.2% | +3971.0% |
Ocular Therapeutix Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $3.79 M(+26.9%) | $951.00 K(-0.8%) | $3.79 M(-0.2%) |
| Sep 2024 | - | $959.00 K(+0.3%) | $3.79 M(+1.9%) |
| Jun 2024 | - | $956.00 K(+3.9%) | $3.72 M(+8.9%) |
| Mar 2024 | - | $920.00 K(-4.0%) | $3.42 M(+14.6%) |
| Dec 2023 | $2.98 M(+41.4%) | $958.00 K(+7.6%) | $2.98 M(+18.6%) |
| Sep 2023 | - | $890.00 K(+36.5%) | $2.52 M(+17.8%) |
| Jun 2023 | - | $652.00 K(+35.0%) | $2.13 M(+4.9%) |
| Mar 2023 | - | $483.00 K(-1.6%) | $2.04 M(-3.5%) |
| Dec 2022 | $2.11 M(-12.9%) | $491.00 K(-3.5%) | $2.11 M(-3.6%) |
| Sep 2022 | - | $509.00 K(-7.8%) | $2.19 M(-3.7%) |
| Jun 2022 | - | $552.00 K(-0.9%) | $2.27 M(-2.5%) |
| Mar 2022 | - | $557.00 K(-2.3%) | $2.33 M(-3.7%) |
| Dec 2021 | $2.42 M(-12.7%) | $570.00 K(-4.0%) | $2.42 M(-3.9%) |
| Sep 2021 | - | $594.00 K(-2.8%) | $2.52 M(-2.7%) |
| Jun 2021 | - | $611.00 K(-5.4%) | $2.59 M(-3.6%) |
| Mar 2021 | - | $646.00 K(-3.1%) | $2.69 M(-3.2%) |
| Dec 2020 | $2.77 M(+9.6%) | $667.00 K(+0.3%) | $2.77 M(-0.3%) |
| Sep 2020 | - | $665.00 K(-5.9%) | $2.78 M(+13.3%) |
| Jun 2020 | - | $707.00 K(-3.7%) | $2.45 M(-1.4%) |
| Mar 2020 | - | $734.00 K(+8.9%) | $2.49 M(-1.7%) |
| Dec 2019 | $2.53 M(+10.7%) | $674.00 K(+98.8%) | $2.53 M(+3.8%) |
| Sep 2019 | - | $339.00 K(-54.3%) | $2.44 M(-8.8%) |
| Jun 2019 | - | $741.00 K(-4.5%) | $2.67 M(+7.0%) |
| Mar 2019 | - | $776.00 K(+33.3%) | $2.50 M(+9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $2.29 M(+40.7%) | $582.00 K(+1.6%) | $2.29 M(+2.4%) |
| Sep 2018 | - | $573.00 K(+1.2%) | $2.23 M(+4.3%) |
| Jun 2018 | - | $566.00 K(+0.2%) | $2.14 M(+11.0%) |
| Mar 2018 | - | $565.00 K(+7.0%) | $1.93 M(+18.7%) |
| Dec 2017 | $1.63 M(+84.4%) | $528.00 K(+9.5%) | $1.63 M(+20.4%) |
| Sep 2017 | - | $482.00 K(+36.2%) | $1.35 M(+24.5%) |
| Jun 2017 | - | $354.00 K(+35.6%) | $1.08 M(+15.7%) |
| Mar 2017 | - | $261.00 K(+3.2%) | $937.00 K(+6.4%) |
| Dec 2016 | $881.00 K(+16.8%) | $253.00 K(+17.1%) | $881.00 K(+6.4%) |
| Sep 2016 | - | $216.00 K(+4.3%) | $828.00 K(+2.7%) |
| Jun 2016 | - | $207.00 K(+1.0%) | $806.00 K(+2.5%) |
| Mar 2016 | - | $205.00 K(+2.5%) | $786.00 K(+4.2%) |
| Dec 2015 | $754.00 K(+37.8%) | $200.00 K(+3.1%) | $754.00 K(+5.0%) |
| Sep 2015 | - | $194.00 K(+3.7%) | $718.00 K(+8.3%) |
| Jun 2015 | - | $187.00 K(+8.1%) | $663.00 K(+5.7%) |
| Mar 2015 | - | $173.00 K(+5.5%) | $627.00 K(+14.6%) |
| Dec 2014 | $547.00 K(+35.4%) | $164.00 K(+18.0%) | $547.00 K(+7.7%) |
| Sep 2014 | - | $139.00 K(-7.9%) | $508.00 K(+10.2%) |
| Jun 2014 | - | $151.00 K(+62.4%) | $461.00 K(+14.1%) |
| Mar 2014 | - | $93.00 K(-25.6%) | $404.00 K(0.0%) |
| Dec 2013 | $404.00 K(0.0%) | $125.00 K(+35.9%) | $404.00 K(+44.8%) |
| Sep 2013 | - | $92.00 K(-2.1%) | $279.00 K(+49.2%) |
| Jun 2013 | - | $94.00 K(+1.1%) | $187.00 K(+101.1%) |
| Mar 2013 | - | $93.00 K | $93.00 K |
| Dec 2012 | $404.00 K | - | - |
FAQ
- What is Ocular Therapeutix annual depreciation & amortization?
- What is the all time high annual D&A for Ocular Therapeutix?
- What is Ocular Therapeutix annual D&A year-on-year change?
- What is Ocular Therapeutix quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly D&A year-on-year change?
- What is Ocular Therapeutix TTM depreciation & amortization?
- What is the all time high TTM D&A for Ocular Therapeutix?
- What is Ocular Therapeutix TTM D&A year-on-year change?
What is Ocular Therapeutix annual depreciation & amortization?
The current annual D&A of OCUL is $3.79 M
What is the all time high annual D&A for Ocular Therapeutix?
Ocular Therapeutix all-time high annual depreciation & amortization is $3.79 M
What is Ocular Therapeutix annual D&A year-on-year change?
Over the past year, OCUL annual depreciation & amortization has changed by +$803.00 K (+26.92%)
What is Ocular Therapeutix quarterly depreciation & amortization?
The current quarterly D&A of OCUL is $951.00 K
What is the all time high quarterly D&A for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly depreciation & amortization is $959.00 K
What is Ocular Therapeutix quarterly D&A year-on-year change?
Over the past year, OCUL quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Ocular Therapeutix TTM depreciation & amortization?
The current TTM D&A of OCUL is $3.79 M
What is the all time high TTM D&A for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM depreciation & amortization is $3.79 M
What is Ocular Therapeutix TTM D&A year-on-year change?
Over the past year, OCUL TTM depreciation & amortization has changed by $0.00 (0.00%)